ATOSSA THERAPEUTICS INC (ATOS:NASDAQ)

$4.85 -0.26 (-5.0881%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 79

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) News Sources

Atos Advances AI-Ready Digital Transformation with Lumen Network as a Service

31-03-2026

yahoo.com

Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for McCune-Albright Syndrome

04-05-2026

yahoo.com

Atos and CNA strengthen long-term strategic partnership through new multi-year infrastructure services agreement

05-05-2026

yahoo.com

Atossa Therapeutics Announces Publication of KARISMA Endoxifen Trial Demonstrating Significant Reduction in Mammographic Breast Density in Healthy Premenopausal Women

06-05-2026

yahoo.com

Atossa Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

08-05-2026

yahoo.com

ATOS: Initiating Coverage of Atossa Therapeutics; Endoxifen’s Expanding Opportunity from Oncology to Orphan Disease

13-05-2026

yahoo.com

Atossa Therapeutics to Host Virtual KOL Event Featuring Dr. Laura Esserman to Discuss Development of (Z)-Endoxifen in ER-Positive Breast Cancer

14-05-2026

yahoo.com

Atos Selected by Viasat to Modernize Global Digital Workplace Operations

19-05-2026

yahoo.com

Atossa Therapeutics Announces ASCO 2026 Abstracts Highlighting (Z)-Endoxifen Activity Across ESR1 Mutations and Ongoing EVANGELINE Phase 2 Trial

27-05-2026

yahoo.com

CEO Chat with Steven Quay, MD, PhD, Chairman, President, & CEO of Atossa Therapeutics

01-06-2026

yahoo.com

ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) Sentiment Trend

0 25 50 75 100 81 71 70 69 88 90 83 81 65 91 31-03-2026 04-05-2026 05-05-2026 06-05-2026 08-05-2026 13-05-2026 14-05-2026 19-05-2026 27-05-2026 01-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) FAQs

toggle

What is the current price of ATOSSA THERAPEUTICS INC (ATOS:NASDAQ)?

The current price of ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) is $4.85.


toggle

ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) absolute price change since previous trading day?

The absolute price change of ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) since the previous trading day is $-0.26.


toggle

ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) percentage price change since previous trading day?

The percentage price change of ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) since the previous trading day is -5.0881%.


toggle

What is the most recent average sentiment score for ATOSSA THERAPEUTICS INC (ATOS:NASDAQ)?

The most recent average sentiment score for ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) is 79 out of 100.


toggle

What is the most recent average sentiment for ATOSSA THERAPEUTICS INC (ATOS:NASDAQ)?

The most recent sentiment for ATOSSA THERAPEUTICS INC (ATOS:NASDAQ) is .


SEC-8K** Filing Available For ATOSSA THERAPEUTICS INC (ATOS:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.